Products Pentacel® (DTaP-IPV/Hib) + Other Pertussis Vaccines
Pentacel® (DTaP-IPV/Hib) + Other Pertussis Vaccines Pre-clinical Completed 💤 Quiet Feb 8, 2010 → Dec 30, 2014
About Pentacel® (DTaP-IPV/Hib) + Other Pertussis Vaccines Pentacel® (DTaP-IPV/Hib) + Other Pertussis Vaccines is a pre-clinical stage product being developed by Sanofi for Pertussis. The current trial status is completed. This product is registered under clinical trial identifier NCT01129362. Target conditions include Pertussis.
Clinical Trials (1) NCT ID Phase Status Start Completion Indication NCT01129362 Pre-clinical Completed Feb 8, 2010 Dec 30, 2014 Pertussis
Product Company Stage Hype Score Adacel® Sanofi Approved aP booster + TdaP booster + Licensed TdaP booster (Boostrix®) Novartis Phase 1 Boostrix + Placebo (Saline) Novartis Approved Acellular pertussis vaccine + Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed) + Licensed TdaP booster vaccine + Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany) Novartis Phase 1 Tetanus Toxoid, acellular pertussis, diphtheria toxoid Sanofi Pre-clinical ADACEL®:Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed + BOOSTRIX®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed Sanofi Approved COVAXIS™: Tetanus, diphtheria, acellular 5-component pertussis, or + inactivated poliovirus vaccine (REPEVAX®) Sanofi Approved (ADACEL®): Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis Sanofi Phase 1/2 DT5aP-IPV-Hib 5-component Pertussis vaccine + Infanrix® -IPV+Hib Sanofi Phase 3 Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis Vaccine and IPV + Hepatitis B vaccine Sanofi Phase 2 DTwP-HepB-Hib-IPV hexavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b, inactivated poliovirus) + DTwP-HepB-Hib pentavalent vaccine (Diphtheria toxoid, Tetanus toxoid, whole cell pertussis, Hepatitis B surface antigen (HBsAg), Haemophilus influenzae type b) + Inactivated Poliomyelitis Vaccine + Poliomyelitis Vaccine bivalent types 1 and 3 + Human Rotavirus, live attenuated + Pneumococcal polysaccharide conjugate vaccine (13-valent, adsorbed) Sanofi Phase 3 Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Combined with Inactivated Poliomyelitis Vaccine Sanofi Approved Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®) + Tetanus, Reduced Diphtheria Toxoid and Acellular Pertussis (ADACEL®) Sanofi Approved DTaP-IPV combined vaccine + DTaP vaccine Sanofi Phase 3 ADACEL®: Tetanus, Reduced Diphtheria and Acellular Pertussis Adsorbed + DECAVAC®: Tetanus and Diphtheria Toxoids Adsorbed Sanofi Approved Tetanus and diphtheria toxoids and acellular pertussis Sanofi Pre-clinical
Other Products from Sanofi